BGLAP and Cowden syndrome 1: These new data together with our own data showing a pronounced effect of TXNIP silencing on OC expression as well as our in vivo data in CS patients may suggest that TXNIP could mediate some adverse effects of glucocorticoids on glucose metabolism through its influence on OC in osteoblasts.